ÂÜÀòÂÒÂ×

Scott DeNobile is a seasoned professional in the biopharmaceutical industry with extensive experience in market access and trade distribution. Currently serving as Vice President of Trade and Distribution at BridgeBio since January 2020, Scott previously held key positions including Vice President of Market Access at Urovant Sciences, Executive Director of Market Access at Neurocrine Biosciences and Pharmacyclics, and various roles at Merck, SuperGen, Bristol-Myers Squibb, and Berlex Biosciences. Scott's educational background includes studies at the Massachusetts College of Pharmacy and Health Sciences, New Hampshire College, and Valencia College.